Olink
Olink offers a high-multiplex technique to identify actionable biomarkers with a strong focus on the human plasma proteome. Their mission is to accelerate proteomics together with the scientific community across multiple disease areas to enable new discoveries and better understand complex real-time human biology.
Latest Content
Product
Advertisement
PEA Technology
Proximity Extension Assay (PEA) technology is the unique technology behind our Olink® Explore platform and Olink® Target 96 and Target 48 panels.
Product
Advertisement
Olink® Signature Q100
Run Olink kits easy and convenient in your own lab with Olink® Signature Q100, a dedicated solution for qPCR readout of Olink panels. With seamless integration between panel analysis to data output, you can simplify your research process with Olink® Target, Olink® Flex and Olink® Focus protein biomarker panels.
Product
Advertisement
Olink® Flex
Olink® Flex is a customizable made-to-order product that enables the selection and combination of up to 21 human proteins into one biomarker panel. Mix and match from ~200 thoroughly pre-validated protein biomarkers.
Product
Advertisement
Build Your Own Panel of Up to 21 Human Protein Biomarkers From a Pre-Validated Library of ∼ 200 Assays Covering Major Disease Areas
Mix and match up to 21 protein assays with 99% combinability. Each and every assay is transparently validated to the highest standards and you can be fully confident that whatever combination of assays you select will work together and deliver high quality data with excellent specificity, sensitivity, and dynamic range
Product
Advertisement
Olink® Flex – Inflammation Research on Your Terms
Olink’s highly flexible made-to-order product, Olink® Flex, enables you to select and combine targets for up to 21 human proteins in one biomarker panel with results reported in absolute quantification (pg/mL) and relative quantification (NPX). Pick and choose from over 200 inflammation-related human proteins with 99% combinability in a broad mix-and-match library.
Webinar
Utilizing NGS for Proteomics - Olink® to Accelerate Drug Discovery and Optimize Clinical Trials Outcome
On-Demand
Speaking at the Advances in Drug Discovery & Development 2022 online symposium, Karsten Strauss from Olink delivered his talk on how Olink are able to provide a platform of products and services that are deployed across major pharmaceutical companies.
Product News
UK Biobank Pharma Proteomics Project Publishes Early Results From its Pioneering Proteomics Research
Olink Holding AB has announced that a publication describing the early findings of proteomics research conducted by the UK Biobank Pharma Proteomics Project was published online to the bioRxiv preprint server.
Webinar
Putting Proteomics at the Heart of Your Multiomics
On-Demand
In this webinar, we host two speakers who will present diverse case studies that will illustrate how multiomics is being used to deepen our understanding of human biology.
Product News
TATAA Biocenter Partners With Olink To Add High Quality Proteomics With Unrivaled Throughput to Their Multiomics Offering
Olink Holding has announced its collaboration with TATAA Biocenter, launching Olink®Explore 3072 proteome profiling service.
eBook
Understanding Real-Time Human Biology
Download this eBook to learn more about how to link genomics with proteomics to accelerate the search for drug targets, understand COVID-Associated Multisystem Inflammatory Syndrome in children and much more.
Advertisement
